JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan
· Delayed Price · Currency is JPY 610.00
-13.00 (-2.09%)
At close: Mar 9, 2026
JCR Pharmaceuticals Revenue
JCR Pharmaceuticals had revenue of 8.99B JPY in the quarter ending December 31, 2025, a decrease of -2.52%. This brings the company's revenue in the last twelve months to 37.55B, up 7.17% year-over-year. In the fiscal year ending March 31, 2025, JCR Pharmaceuticals had annual revenue of 33.07B, down -22.86%.
Revenue (ttm)
37.55B
Revenue Growth
+7.17%
P/S Ratio
1.98
Revenue / Employee
38.04M
Employees
987
Market Cap
74.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 33.07B | -9.80B | -22.86% |
| Mar 31, 2024 | 42.87B | 8.53B | 24.83% |
| Mar 31, 2023 | 34.34B | -16.74B | -32.77% |
| Mar 31, 2022 | 51.08B | 21.00B | 69.79% |
| Mar 31, 2021 | 30.09B | 5.30B | 21.40% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Santen Pharmaceutical | 287.99B |
| Kyowa Kirin | 496.83B |
| Ono Pharmaceutical | 509.35B |
| Perseus Proteomics | 140.41M |
| Astellas Pharma | 2,060.61B |
| Daiichi Sankyo Company | 2,052.15B |
| Otsuka Holdings | 2,468.89B |
| Chugai Pharmaceutical | 1,257.94B |